Cresco Labs Inc.
CRLBF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $164,913 | $163,624 | $165,757 | $174,420 |
| % Growth | 0.8% | -1.3% | -5% | – |
| Cost of Goods Sold | $85,553 | $80,368 | $87,126 | $91,883 |
| Gross Profit | $79,360 | $83,256 | $78,631 | $82,537 |
| % Margin | 48.1% | 50.9% | 47.4% | 47.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $5,116 | $0 | $3,495 |
| SG&A Expenses | $59,167 | $57,850 | $65,042 | $42,050 |
| Sales & Mktg Exp. | $0 | $3,534 | $0 | $3,888 |
| Other Operating Expenses | $2,365 | $9,265 | $0 | $21,081 |
| Operating Expenses | $61,532 | $67,115 | $65,042 | $63,131 |
| Operating Income | $17,828 | $16,141 | $13,589 | $19,406 |
| % Margin | 10.8% | 9.9% | 8.2% | 11.1% |
| Other Income/Exp. Net | -$27,929 | -$13,398 | -$14,507 | -$16,351 |
| Pre-Tax Income | -$10,101 | $2,743 | -$918 | $3,055 |
| Tax Expense | $11,867 | $16,636 | $14,316 | $2,616 |
| Net Income | -$17,054 | -$16,334 | -$14,432 | -$4,372 |
| % Margin | -10.3% | -10% | -8.7% | -2.5% |
| EPS | -0.048 | -0.046 | -0.041 | -0.013 |
| % Growth | -3% | -12.2% | -226.2% | – |
| EPS Diluted | -0.048 | -0.046 | -0.041 | -0.013 |
| Weighted Avg Shares Out | 357,415 | 354,295 | 350,243 | 349,099 |
| Weighted Avg Shares Out Dil | 357,415 | 354,295 | 350,243 | 349,099 |
| Supplemental Information | – | – | – | – |
| Interest Income | $699 | $1,333 | $811 | $657 |
| Interest Expense | $15,266 | $13,895 | $15,667 | $13,736 |
| Depreciation & Amortization | $14,706 | $14,039 | $14,698 | $15,636 |
| EBITDA | $19,871 | $30,677 | $29,447 | $32,427 |
| % Margin | 12% | 18.7% | 17.8% | 18.6% |